Hogan Lovells is representing Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, in filing for voluntary relief under Chapter 11…
Represents Orexigen Therapeutics’ Chapter 11
Hogan Lovells is representing Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company focused on the treatment of obesity, in filing for voluntary relief under Chapter 11…